4.26
-0.0859(-1.98%)
Currency In USD
| Previous Close | 4.35 |
| Open | 4.23 |
| Day High | 4.52 |
| Day Low | 4.23 |
| 52-Week High | 14.8 |
| 52-Week Low | 3.03 |
| Volume | 13,587 |
| Average Volume | 41,353 |
| Market Cap | 3.89M |
| PE | -0.92 |
| EPS | -4.61 |
| Moving Average 50 Days | 4.28 |
| Moving Average 200 Days | 4.12 |
| Change | -0.09 |
If you invested $1000 in Titan Pharmaceuticals, Inc. (TTNP) 10 years ago, it would be worth $0.25 as of June 23, 2025 at a share price of $4.259. Whereas If you bought $1000 worth of Titan Pharmaceuticals, Inc. (TTNP) shares 5 years ago, it would be worth $21.51 as of June 23, 2025 at a share price of $4.259.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
GlobeNewswire Inc.
Jun 03, 2025 12:45 PM GMT
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration state
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
GlobeNewswire Inc.
Apr 11, 2025 8:15 PM GMT
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
GlobeNewswire Inc.
Nov 27, 2024 9:05 PM GMT
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market